Karapolat I - Search Results

1

¹⁸F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.

Öztürk H, Karapolat I. Öztürk H, et al. Among authors: karapolat i. Oncol Lett. 2016 Jan;11(1):316-322. doi: 10.3892/ol.2015.3903. Epub 2015 Nov 10. Oncol Lett. 2016. PMID: 26870210 Free PMC article.

2

Efficacy of ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.

Öztürk H, Karapolat I. Öztürk H, et al. Among authors: karapolat i. Exp Ther Med. 2015 Mar;9(3):717-724. doi: 10.3892/etm.2015.2187. Epub 2015 Jan 16. Exp Ther Med. 2015. PMID: 25667618 Free PMC article.

3

Bilateral metachronous adrenal metastases of operated renal cell carcinoma.

Ozturk H, Karapolat I, Saklamaz A. Ozturk H, et al. Among authors: karapolat i. Urologia. 2015 Apr-Jun;82(2):114-7. doi: 10.5301/uro.5000094. Epub 2014 Nov 25. Urologia. 2015. PMID: 25451879

4

The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.

Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yilmaz Y, Oktay Tarhan M. Cokmert S, et al. Among authors: karapolat i. J BUON. 2016 Nov-Dec;21(6):1410-1418. J BUON. 2016. PMID: 28039701 Free article.

5

Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?

Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K. Karapolat I, et al. Nuklearmedizin. 2013 Dec 13;52(6):244-9. doi: 10.3413/Nukmed-0597-13-06. Epub 2013 Oct 1. Nuklearmedizin. 2013. PMID: 24081426

6

Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis.

Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioğlu K, Pirildar T, Aksu K. Karapolat I, et al. Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S15-21. Epub 2012 Oct 22. Clin Exp Rheumatol. 2013. PMID: 23075530

7

Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases.

Karapolat I, Kumanlıoğlu K. Karapolat I, et al. Mol Imaging Radionucl Ther. 2012 Aug;21(2):63-8. doi: 10.4274/Mirt.344. Epub 2012 Aug 1. Mol Imaging Radionucl Ther. 2012. PMID: 23487242 Free PMC article.

8

Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma.

Karapolat I, Oncel G, Kumanlıoğlu K. Karapolat I, et al. Mol Imaging Radionucl Ther. 2013 Apr;22(1):18-20. doi: 10.4274/Mirt.258. Epub 2013 Apr 5. Mol Imaging Radionucl Ther. 2013. PMID: 23610727 Free PMC article.

9

Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up.

Hatipoğlu F, Karapolat İ, Ömür Ö, Akgün A, Yanarateş A, Kumanlıoğlu K. Hatipoğlu F, et al. Among authors: karapolat i. Mol Imaging Radionucl Ther. 2016 Jun 5;25(2):85-90. doi: 10.4274/mirt.35220. Mol Imaging Radionucl Ther. 2016. PMID: 27277325 Free PMC article.

10

Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.

Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Akgun A, et al. Among authors: karapolat i. Ann Nucl Med. 2006 May;20(4):269-75. doi: 10.1007/BF02984643. Ann Nucl Med. 2006. PMID: 16856570 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters